TUBGCP5 Antibody

What is TUBGCP5 and what cellular functions does it serve?

TUBGCP5 (Gamma-tubulin complex component 5 or GCP5) is a crucial component of the gamma-tubulin ring complex (γTuRC) that plays an essential role in microtubule nucleation at the centrosome . The protein functions as part of a macromolecular complex that serves as a template for microtubule assembly, controlling both the timing and spatial organization of the microtubule cytoskeleton. TUBGCP5 contributes to proper spindle formation during mitosis and is necessary for maintaining cellular architecture. The protein has a molecular weight of approximately 118 kDa and belongs to the TUBGCP protein family . Understanding TUBGCP5's function provides context for antibody-based detection and analysis in research settings.

What applications are TUBGCP5 antibodies validated for?

TUBGCP5 antibodies have been validated for multiple laboratory applications, primarily Western blotting (WB), immunohistochemistry (IHC), and enzyme-linked immunosorbent assay (ELISA) . Based on available validation data, Western blotting represents the most commonly verified application, with recommended dilution ranges typically between 1:500-1:2000 . For immunohistochemistry, suggested dilutions generally fall within 1:100-1:300 . ELISA applications may require significantly higher dilutions, with some products recommending 1:20000 . It's important to note that optimal dilutions should be determined empirically for each specific experimental condition, as factors such as tissue type, fixation method, and detection system can influence antibody performance.

Which species reactivity is available for TUBGCP5 antibodies?

Commercial TUBGCP5 antibodies demonstrate reactivity across multiple mammalian species. The most commonly available antibodies react with human TUBGCP5, while many also cross-react with mouse and rat orthologs . This cross-reactivity is beneficial for comparative studies across model organisms. The amino acid sequence conservation in functional domains of TUBGCP5 across these species enables this cross-reactivity, though researchers should verify specific epitope conservation when working with non-validated species. When selecting an antibody for a particular research application, it's crucial to check the manufacturer's validation data for the species of interest, as reactivity may vary between antibody clones based on the immunogen sequence used .

How should TUBGCP5 antibodies be stored and handled to maintain optimal activity?

TUBGCP5 antibodies require specific storage and handling conditions to preserve their immunoreactivity. For long-term storage, manufacturers consistently recommend maintaining the antibodies at -20°C for up to one year . For frequent use and short-term storage (up to one month), antibodies can be kept at 4°C . It's critical to avoid repeated freeze-thaw cycles, as these can lead to antibody degradation and loss of activity. Most commercial TUBGCP5 antibodies are supplied in liquid form containing stabilizers such as glycerol (typically 50%), BSA (0.5%), and sodium azide (0.02%) in PBS buffer . When working with these antibodies, it's advisable to prepare small aliquots upon receipt to minimize freeze-thaw cycles. Additionally, when removing antibodies from storage, allow them to equilibrate to room temperature before opening to prevent condensation that could promote bacterial contamination.

What controls should be included when using TUBGCP5 antibodies in Western blotting?

When designing Western blot experiments with TUBGCP5 antibodies, several controls are essential for result validation:

The inclusion of transfected versus non-transfected 293T cells provides an excellent system for antibody validation, as demonstrated in published Western blot images . When probing for TUBGCP5, a band should be detected at approximately 118 kDa, which corresponds to the predicted molecular weight of the protein . Variations in band pattern or molecular weight may indicate post-translational modifications, splice variants, or potential cross-reactivity with other GCP family members.

What are the optimal immunohistochemistry conditions for TUBGCP5 detection?

For successful immunohistochemical detection of TUBGCP5, specific protocol parameters should be considered. Based on validation data, the following conditions are recommended for paraffin-embedded tissue sections:

• Antibody dilution: 1:100-1:300 range, with 1:100 being most commonly validated

• Incubation temperature: 4°C for optimal results

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0) is typically required for formalin-fixed tissues

• Detection system: Avidin-biotin complex (ABC) or polymer-based detection systems are suitable

• Counterstaining: Hematoxylin provides good nuclear contrast

Published validation images demonstrate successful TUBGCP5 detection in human brain tissue sections . When optimizing IHC protocols, it's advisable to test multiple antibody dilutions and incubation times. The subcellular localization pattern should primarily show centrosomal and cytoplasmic staining, with potential nuclear signal depending on cell cycle stage. Non-specific background staining can be minimized through appropriate blocking steps and careful optimization of washing procedures.

How can TUBGCP5 antibodies be used to study γTuRC assembly and function?

TUBGCP5 antibodies provide powerful tools for investigating γTuRC assembly dynamics and functional properties through multiple advanced approaches:

• Co-immunoprecipitation (Co-IP): TUBGCP5 antibodies can be used to pull down intact γTuRC complexes, enabling analysis of protein-protein interactions within the complex. This approach can reveal how TUBGCP5 associates with other components like γ-tubulin, GCP2, GCP3, GCP4, and GCP6 .

• Proximity labeling: Combining TUBGCP5 antibodies with proximity ligation assays (PLA) can map the spatial organization of proteins within the γTuRC structure at nanometer resolution.

• Functional blocking experiments: In cell-free microtubule nucleation assays, TUBGCP5 antibodies can be used to selectively inhibit γTuRC function, providing insights into the specific contribution of TUBGCP5 to nucleation activity.

• Cell cycle analysis: Immunofluorescence with TUBGCP5 antibodies can track γTuRC localization and abundance throughout the cell cycle, particularly during mitotic spindle formation.

When designing such experiments, it's crucial to verify that the epitope recognized by the antibody doesn't interfere with protein-protein interactions of interest. The immunogen information provided by manufacturers helps in making this determination . For instance, antibodies targeting amino acids 746-794 or 741-790 of human TUBGCP5 recognize the C-terminal region of the protein .

What methodological approaches can resolve discrepancies in TUBGCP5 antibody results?

When confronted with inconsistent results using TUBGCP5 antibodies, several methodological approaches can help identify and resolve discrepancies:

• Multiple antibody validation: Utilize different antibodies recognizing distinct epitopes of TUBGCP5. For instance, compare results between antibodies targeting the C-terminal region (aa 741-790) and those against full-length protein .

• Genetic validation: Implement siRNA knockdown or CRISPR/Cas9 knockout of TUBGCP5 to confirm antibody specificity. Reduced or absent signal in knockout samples strongly supports antibody specificity.

• Recombinant protein controls: Express tagged recombinant TUBGCP5 (e.g., His-tagged or GFP-fusion) as a defined control for antibody recognition.

• Mass spectrometry validation: Following immunoprecipitation with TUBGCP5 antibodies, analyze pulled-down proteins by mass spectrometry to confirm identity.

• Cross-reactivity assessment: Test potential cross-reactivity with other TUBGCP family members (GCP2-4, GCP6) through expression of individual proteins in heterologous systems.

When troubleshooting western blotting specifically, careful optimization of protein extraction methods is crucial since centrosomal proteins like TUBGCP5 may require specialized extraction buffers to ensure complete solubilization of centrosome-associated proteins.

How can TUBGCP5 antibodies be integrated with super-resolution microscopy techniques?

Integrating TUBGCP5 antibodies with super-resolution microscopy enables detailed visualization of centrosome architecture and γTuRC organization beyond the diffraction limit of conventional microscopy. For optimal results with these advanced imaging approaches:

• Antibody labeling optimization: For STORM or PALM microscopy, TUBGCP5 antibodies can be directly conjugated to photoswitchable fluorophores or used with appropriate secondary antibodies. For optimal signal-to-noise ratio, dilutions may need to be adjusted from standard immunofluorescence protocols, typically using higher concentrations (1:50-1:100) .

• Multi-color imaging strategy: Combine TUBGCP5 antibodies with other centrosomal markers (e.g., γ-tubulin, pericentrin) to create comprehensive spatial maps of the centrosome organization.

• Sample preparation considerations: Super-resolution techniques require meticulous fixation and permeabilization optimization. Paraformaldehyde fixation (4%) followed by controlled permeabilization with 0.1-0.2% Triton X-100 typically provides good results for centrosomal proteins.

• Validation approaches: Compare structural patterns observed in super-resolution with electron microscopy data or correlative light-electron microscopy approaches to confirm the biological relevance of observed structures.

When implementing these techniques, it's essential to include appropriate controls to distinguish true signal from potential artifacts, particularly since super-resolution microscopy can amplify even minor non-specific binding of antibodies.

What are common causes of false negative results when using TUBGCP5 antibodies?

False negative results when using TUBGCP5 antibodies can stem from multiple technical factors that should be methodically addressed:

• Epitope masking: Post-translational modifications or protein-protein interactions may obscure the antibody epitope. This is particularly relevant for TUBGCP5, which functions within the large γTuRC complex. Using antibodies that recognize different epitopes may help overcome this issue .

• Insufficient protein extraction: Centrosomal proteins like TUBGCP5 can be difficult to extract fully using standard lysis buffers. Optimization with detergents (1-2% NP-40 or Triton X-100) and mechanical disruption may improve extraction efficiency.

• Protein degradation: TUBGCP5 may be subject to proteolytic degradation during sample preparation. Including complete protease inhibitor cocktails in all buffers is essential.

• Insufficient antigen retrieval: For IHC applications, inadequate antigen retrieval can prevent antibody access to TUBGCP5 epitopes in fixed tissues. Heat-induced epitope retrieval at optimal pH (typically pH 6.0 citrate buffer) should be carefully optimized .

• Antibody degradation: Improper storage or repeated freeze-thaw cycles can compromise antibody activity. Following storage recommendations (-20°C for long-term, 4°C for short-term use) and preparing small aliquots can prevent this issue .

If false negative results persist despite addressing these factors, verification of TUBGCP5 expression in the sample type through RT-PCR or mRNA analysis can determine whether the protein should be present in detectable amounts.

How can non-specific binding be distinguished from true TUBGCP5 signal?

Distinguishing non-specific binding from authentic TUBGCP5 signal requires implementation of multiple control strategies:

• Blocking peptide competition: Pre-incubating the TUBGCP5 antibody with excess immunizing peptide should abolish specific staining while leaving non-specific binding intact. This approach is particularly valuable for antibodies where the immunogen information is available, such as those targeting amino acids 741-790 or 746-794 of human TUBGCP5 .

• Genetic controls: Analysis of samples with TUBGCP5 knockdown or knockout provides the most definitive control. In the absence of genetic manipulation, comparing tissues or cell lines with known differential expression of TUBGCP5 can serve as alternatives.

• Signal characteristics analysis: True TUBGCP5 signal should localize predominantly to centrosomes, appearing as distinct punctate structures that often colocalize with other centrosomal markers like γ-tubulin. In western blots, the major band should appear at approximately 118 kDa .

• Secondary antibody-only controls: Samples processed without primary antibody can reveal background arising from secondary antibody binding.

• Isotype controls: Using matched isotype control antibodies (typically rabbit or mouse IgG at the same concentration) can identify non-specific binding due to Fc receptor interactions or other antibody class-related factors .

When evaluating IHC results specifically, comparing staining patterns with published literature and cell biology knowledge of TUBGCP5 distribution helps distinguish authentic signal from artifacts.

What techniques can improve signal-to-noise ratio when working with TUBGCP5 antibodies?

Enhancing signal-to-noise ratio for TUBGCP5 detection requires optimization across multiple experimental parameters:

• Antibody titration: Systematic testing of antibody dilutions from 1:100 to 1:2000 for WB and 1:50 to 1:300 for IHC/ICC can identify the optimal concentration that maximizes specific signal while minimizing background .

• Blocking optimization: For centrosomal proteins like TUBGCP5, blocking with 5% BSA or 5% milk supplemented with 0.1-0.3% Triton X-100 can reduce non-specific binding while maintaining accessibility to centrosomal structures.

• Enhanced washing protocols: Implementing longer or additional washing steps with PBS containing 0.1% Tween-20 (for WB) or 0.1% Triton X-100 (for IHC/ICC) can substantially reduce background.

• Signal amplification systems: For low-abundance detection, tyramide signal amplification (TSA) or polymer-based detection systems can enhance sensitivity without proportionally increasing background.

• Sample preparation refinement: For centrosomal proteins, methanol fixation (-20°C for 10 minutes) often provides superior preservation and accessibility compared to paraformaldehyde fixation alone.

• Antigen retrieval optimization: For IHC applications, comparing different antigen retrieval methods (heat-induced epitope retrieval with citrate buffer pH 6.0 versus EDTA buffer pH 9.0) can identify conditions that maximize TUBGCP5 epitope accessibility .

Implementation of these optimizations should proceed systematically, changing one variable at a time to identify the specific factors that most significantly impact signal quality in your experimental system.

What are the key differences between polyclonal and monoclonal TUBGCP5 antibodies?

Polyclonal and monoclonal TUBGCP5 antibodies offer distinct advantages and limitations that should inform selection for specific research applications:

Polyclonal TUBGCP5 antibodies, like those described in the search results (rabbit polyclonal antibodies ), offer broader epitope recognition, which can be advantageous when protein conformation or post-translational modifications might mask individual epitopes. Monoclonal antibodies provide higher consistency between experiments and potentially greater specificity. For initial characterization studies, polyclonal antibodies often provide higher sensitivity, while monoclonal antibodies may be preferable for standardized assays requiring absolute reproducibility.

How do different TUBGCP5 antibody preparation methods affect experimental outcomes?

The preparation method of TUBGCP5 antibodies significantly influences their performance characteristics and optimal applications:

• Immunogen design impact: Antibodies generated against synthetic peptides (such as those targeting amino acids 741-790 or 746-794 of human TUBGCP5 ) typically recognize linear epitopes and perform well in applications where proteins are denatured, like Western blotting. In contrast, antibodies raised against recombinant full-length TUBGCP5 protein may better recognize native conformations for applications like immunoprecipitation.

• Purification methodology effects: Affinity-purified antibodies using epitope-specific immunogens typically offer higher specificity than crude antisera. This purification reduces potential cross-reactivity with other TUBGCP family members that share sequence homology.

• Buffer composition considerations: The presence of stabilizers and preservatives in antibody preparations affects storage stability and compatibility with certain applications. Most TUBGCP5 antibodies are supplied in PBS containing 50% glycerol, 0.02% sodium azide, and sometimes BSA (0.5%) . These components protect antibody integrity during storage but may interfere with certain applications (e.g., sodium azide inhibits HRP activity).

• Antibody concentration standardization: Standardized antibody concentrations (typically 1 mg/ml ) enable more consistent protocol development, while variable concentration preparations require application-specific titration.

When transitioning between different antibody preparations, optimization of experimental protocols is essential, as dilution recommendations and performance characteristics may vary significantly between products, even when targeting the same region of TUBGCP5.

How can TUBGCP5 antibodies contribute to understanding centrosome dysfunction in disease?

TUBGCP5 antibodies offer powerful tools for investigating the role of centrosome abnormalities in various diseases through multiple research approaches:

• Cancer research applications: TUBGCP5 antibodies can help characterize centrosome amplification, a hallmark of many cancer types. Immunohistochemical analysis of tumor samples using optimized TUBGCP5 antibody protocols (1:100-1:300 dilution ) could reveal correlations between centrosome abnormalities and clinical outcomes.

• Neurodevelopmental disorder investigations: TUBGCP5 is located within the 15q11.2 BP1-BP2 microdeletion region associated with neurodevelopmental disorders. Antibody-based studies can examine whether TUBGCP5 haploinsufficiency alters centrosome function in patient-derived cells.

• Ciliopathy research: As centrosomes serve as basal bodies for primary cilia, TUBGCP5 antibodies can help explore connections between γTuRC dysfunction and ciliopathies by examining centrosome-to-basal body transition.

• Therapeutic target validation: In contexts where centrosome dysfunction drives pathology, TUBGCP5 antibodies can validate potential therapeutic approaches targeting the γTuRC through immunofluorescence or biochemical assays.

• Biomarker development: Quantitative analysis of TUBGCP5 levels or post-translational modifications using validated antibodies could potentially serve as biomarkers for diseases associated with centrosome dysfunction.

When designing such disease-focused studies, selection of TUBGCP5 antibodies with validated reactivity in relevant species and sample types is crucial for generating translatable results.

What emerging technologies might enhance TUBGCP5 antibody applications?

Several cutting-edge technologies are poised to expand the utility and information yield of TUBGCP5 antibody-based research:

• Multiplexed antibody imaging: Technologies like Imaging Mass Cytometry (IMC) or CODEX allow simultaneous visualization of dozens of proteins, enabling comprehensive analysis of TUBGCP5 in the context of the entire centrosome proteome and cellular state.

• Intrabody applications: Converting TUBGCP5 antibodies into intrabodies (intracellularly expressed antibody fragments) could enable live-cell tracking of TUBGCP5 dynamics during centrosome duplication and mitosis.

• Nanobody development: Generating TUBGCP5-specific nanobodies (single-domain antibody fragments) could provide superior tissue penetration and reduced steric hindrance for super-resolution microscopy applications.

• Proximity-based proteomics: Adapting TUBGCP5 antibodies for TurboID or APEX2 proximity labeling would enable comprehensive mapping of the TUBGCP5 interactome in different cellular contexts.

• Cryo-electron tomography integration: Using gold-conjugated TUBGCP5 antibodies as fiducial markers for correlative light and electron microscopy could bridge structural and functional studies of γTuRC complexes.

• Single-cell proteomics applications: Adapting TUBGCP5 antibodies for emerging single-cell proteomic technologies would allow analysis of centrosome protein variation at unprecedented resolution.

Implementation of these technologies may require modification of existing TUBGCP5 antibodies or development of new reagents optimized for specific applications. Researchers should carefully validate antibody performance in each new technological context.